Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party

A. Bazarbachi; A. Boumendil; H. Finel; M. Mohty; L. Castagna; D. Blaise; K.S. Peggs; B. Afanasyev; J.L. Diez-Martin; P. Corradini; D. Michonneau; S. Robinson; G. Gutiérrez García; F. Bonifazi; I. Yakoub-Agha; Z. Gülbas; A. Bloor; J. Delage; A. Esquirol; R. Malladi; C. Scheid; J. El-Cheikh; H. Ghesquières; S. Montoto; P. Dreger; A. Sureda

doi:10.1002/cncr.31755

Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party

A. Bazarbachi, A. Boumendil, H. Finel, M. Mohty, L. Castagna, D. Blaise, K.S. Peggs, B. Afanasyev, J.L. Diez-Martin, P. Corradini, D. Michonneau, S. Robinson, G. Gutiérrez García, F. Bonifazi, I. Yakoub-Agha, Z. Gülbas, A. Bloor, J. Delage, A. Esquirol, R. MalladiC. Scheid, J. El-Cheikh, H. Ghesquières, S. Montoto, P. Dreger, A. Sureda

Research output: Contribution to journal › Article

Original language	English
Pages (from-to)	90-98
Number of pages	9
Journal	Cancer
Volume	125
Issue number	1
DOIs	https://doi.org/10.1002/cncr.31755
Publication status	Published - 2019

Cite this

Bazarbachi, A., Boumendil, A., Finel, H., Mohty, M., Castagna, L., Blaise, D., ... Sureda, A. (2019). Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party. Cancer, 125(1), 90-98. https://doi.org/10.1002/cncr.31755

Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party. / Bazarbachi, A.; Boumendil, A.; Finel, H.; Mohty, M.; Castagna, L.; Blaise, D.; Peggs, K.S.; Afanasyev, B.; Diez-Martin, J.L.; Corradini, P.; Michonneau, D.; Robinson, S.; Gutiérrez García, G.; Bonifazi, F.; Yakoub-Agha, I.; Gülbas, Z.; Bloor, A.; Delage, J.; Esquirol, A.; Malladi, R.; Scheid, C.; El-Cheikh, J.; Ghesquières, H.; Montoto, S.; Dreger, P.; Sureda, A.

In: Cancer, Vol. 125, No. 1, 2019, p. 90-98.

Research output: Contribution to journal › Article

Bazarbachi, A, Boumendil, A, Finel, H, Mohty, M, Castagna, L, Blaise, D, Peggs, KS, Afanasyev, B, Diez-Martin, JL, Corradini, P, Michonneau, D, Robinson, S, Gutiérrez García, G, Bonifazi, F, Yakoub-Agha, I, Gülbas, Z, Bloor, A, Delage, J, Esquirol, A, Malladi, R, Scheid, C, El-Cheikh, J, Ghesquières, H, Montoto, S, Dreger, P & Sureda, A 2019, 'Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party', Cancer, vol. 125, no. 1, pp. 90-98. https://doi.org/10.1002/cncr.31755

Bazarbachi, A. ; Boumendil, A. ; Finel, H. ; Mohty, M. ; Castagna, L. ; Blaise, D. ; Peggs, K.S. ; Afanasyev, B. ; Diez-Martin, J.L. ; Corradini, P. ; Michonneau, D. ; Robinson, S. ; Gutiérrez García, G. ; Bonifazi, F. ; Yakoub-Agha, I. ; Gülbas, Z. ; Bloor, A. ; Delage, J. ; Esquirol, A. ; Malladi, R. ; Scheid, C. ; El-Cheikh, J. ; Ghesquières, H. ; Montoto, S. ; Dreger, P. ; Sureda, A. / Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party. In: Cancer. 2019 ; Vol. 125, No. 1. pp. 90-98.

@article{cb6f04729560454b8b9e7d4ea5b74ac6,

title = "Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party",

author = "A. Bazarbachi and A. Boumendil and H. Finel and M. Mohty and L. Castagna and D. Blaise and K.S. Peggs and B. Afanasyev and J.L. Diez-Martin and P. Corradini and D. Michonneau and S. Robinson and {Guti{\'e}rrez Garc{\'i}a}, G. and F. Bonifazi and I. Yakoub-Agha and Z. G{\"u}lbas and A. Bloor and J. Delage and A. Esquirol and R. Malladi and C. Scheid and J. El-Cheikh and H. Ghesqui{\`e}res and S. Montoto and P. Dreger and A. Sureda",

note = "Cited By :3 Export Date: 12 February 2020",

year = "2019",

doi = "10.1002/cncr.31755",

language = "English",

volume = "125",

pages = "90--98",

journal = "Cancer",

issn = "0008-543X",

publisher = "John Wiley and Sons Inc.",

number = "1",

}

TY - JOUR

T1 - Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party

AU - Bazarbachi, A.

AU - Boumendil, A.

AU - Finel, H.

AU - Mohty, M.

AU - Castagna, L.

AU - Blaise, D.

AU - Peggs, K.S.

AU - Afanasyev, B.

AU - Diez-Martin, J.L.

AU - Corradini, P.

AU - Michonneau, D.

AU - Robinson, S.

AU - Gutiérrez García, G.

AU - Bonifazi, F.

AU - Yakoub-Agha, I.

AU - Gülbas, Z.

AU - Bloor, A.

AU - Delage, J.

AU - Esquirol, A.

AU - Malladi, R.

AU - Scheid, C.

AU - El-Cheikh, J.

AU - Ghesquières, H.

AU - Montoto, S.

AU - Dreger, P.

AU - Sureda, A.

N1 - Cited By :3 Export Date: 12 February 2020

PY - 2019

Y1 - 2019

U2 - 10.1002/cncr.31755

DO - 10.1002/cncr.31755

M3 - Article

VL - 125

SP - 90

EP - 98

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 1

ER -

Access to Document

10.1002/cncr.31755

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85055479928&doi=10.1002%2fcncr.31755&partnerID=40&md5=0240d324c0f6cc56d9358ad645e20898

Projects

ISTITUTO TUMORI MILANO - RICERCA SANITARIA E "OUTCOME RESEARCH"

Project: Other project

Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party

Cite this

Access to Document

Related content

Projects

ISTITUTO TUMORI MILANO - RICERCA SANITARIA E "OUTCOME RESEARCH"